EntreMed Shares Up on Results of Drug Study
608549
Drug developer EntreMed Inc. said Wednesday that an animal study suggests its lead product candidate, a cancer drug called Panzem, can effectively slow growth of head and neck tumors.
704148
Shares of NeoPharm Inc. jumped 7 percent Thursday morning after the troubled biotechnology company said it regained licenses for two key cancer medications from Pfizer Inc.
556932
Shares of Biocryst Pharmaceuticals Inc. (BCRX.O: Quote, Profile, Research) rose on Tuesday after the company received &quot;orphan drug&quot; status for an anti-cancer compound.
697549
New drug prospects push shares to a new 52-week high.
29498
Despite its fourth-quarter loss, the pharmaceutical giantâs results topped Wall Street estimates, and its shares rose more than 5 percent.
455559
Doctors researching breast cancer say a new drug has had "exciting" results.
681361
Australian biotech group Metabolic  Pharmaceuticals Ltd. said on Monday a clinical trial showed its  new weight-loss drug was effective and free of side effects,  sending its shares soaring 28 percent.
361386
Introgen Therapeutics Inc., a gene therapy company, on Thursday said its experimental breast cancer treatment showed promise in a mid-stage clinical trial, driving its shares up 24 percent.
449256
GlaxoSmithKline PLC, the world's second-largest drug maker, began a campaign to challenge a report that linked its diabetes drug Avandia to heart risks and caused its stock to decline 11 percent in the eight days through Tuesday. The shares rose yesterday.
751523
A new addition to an already successful drug promises good results for investors.
478980
Shares of German drugmaker Merck KGaA climbed sharply Tuesday after the company released successful new study results for its cancer drug Erbitux. Shares of biotechnology company ImClone, which developed the drug, soared nearly 24 percent in the U.S.
768183
An experimental drug from Sanofi-Aventis, viewed as pivotal to the newly merged company's future, showed good results in the largest clinical study of the product to date.
421539
This morning, Pfizer (nyse: PFE - news - people ) announced that it had received data from two long-term studies in using its arthritis drug Celebrex to prevent cancer.
379182
Merck KGaA's cancer drug cilengitide showed encouraging results in a Phase I study in the treatment of glioma, an aggressive form of brain tumor, the German drugs and chemicals group said on Monday.
640929
Shares of Cambridge-based Genzyme were up slightly today on news that the drug maker won approval for a drug to treat childhood leukemia.
646566
Stocks rose at the open on Monday, boosted by takeover news and stronger-than-expected earnings in the pharmaceutical sector.
184796
Shares of OSI Pharmaceuticals Inc.  OSIP.O jumped 13 percent in pre-market trade on Monday after  the company's experimental drug was shown to prolong the lives  of patients with cancer of the pancreas.